ADMA vs LRCX · P/E 22, rev $238.9M vs P/E 71, rev $23.23B
ADMA Biologics Inc (ADMA) versus Lam Research Corp (LRCX) — a side-by-side from cached financials, not a winner call.
ADMA Biologics Inc (ADMA) is a biotechnology company listed on US.
Lam Research Corp (LRCX) is a semiconductor equipment & materials company listed on NASDAQ. It is led by Timothy M. Archer.
Latest reported ADMA revenue for 2026-06-30 was $238.9M. Net income was $83.2M. ADMA currently screens at market cap $4.39B and trailing P/E 21.9.
Latest reported LRCX revenue for 2026-06-28 was $23.23B. Net income was $7.27B. LRCX currently screens at market cap $467.94B and trailing P/E 70.9.
ADMA currently screens at market cap $4.39B and trailing P/E 21.9. LRCX currently screens at market cap $467.94B and trailing P/E 70.9.
Not investment advice. Open the ADMA and LRCX stock pages for the full models.
Not investment advice.